amiodarone has been researched along with Heart Arrest in 161 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Heart Arrest: Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Japan, intravenous nifekalant (NIF) was often used for direct current cardioversion-resistant ventricular fibrillation (VF), until the use of intravenous amiodarone (AMD) was approved in 2007." | 9.14 | Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. ( Akieda, K; Amino, M; Fujibayashi, D; Fukushima, T; Hashida, T; Higami, S; Inokuchi, S; Kodama, I; Morita, S; Opthof, T; Otsuka, H; Shima, M; Tamura, K; Tanabe, T; Uemura, S; Yoshioka, K, 2010) |
| "As compared with lidocaine, amiodarone leads to substantially higher rates of survival to hospital admission in patients with shock-resistant out-of-hospital ventricular fibrillation." | 9.10 | Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. ( Barr, A; Cass, D; Cooper, R; Dorian, P; Gelaznikas, R; Schwartz, B, 2002) |
| "This study was undertaken to determine the association between amiodarone therapy and risk of complications of cardiac surgery in patients in the randomized placebo-controlled, double-blind Canadian Amiodarone Myocardial Infarction Arrhythmia Trial." | 9.10 | Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). ( Cairns, JA; Connolly, SJ; Crystal, E; Dorian, P; Gent, M; Kahn, S; Roberts, R; Thorpe, K, 2003) |
| "To describe the successful management of ventricular fibrillation (VF) and ventricular tachycardia (VT) using cardiopulmonary resuscitation, including defibrillation, followed by continuous rate infusion of IV amiodarone, in a cat with cardiac arrest secondary to tachyarrhythmia." | 7.96 | Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat. ( Berlin, N; Kelmer, E; Maiorkis, I; Ohad, DG, 2020) |
| "We describe a case of amiodarone-induced thyrotoxicosis (AIT) with cardiopulmonary arrest (CPA) in a 49-year-old woman." | 7.88 | Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest. ( Hasegawa, N; Inoue, K; Kakuta, Y; Kondo, T; Kowase, S; Miki, K; Nishikawa, T; Omura, M; Saito, J; Sugisawa, C; Tsurutani, Y, 2018) |
| "To compare the effects of amiodarone administration by humerus intraosseous (HIO) and intravenous (IV) routes on return of spontaneous circulation (ROSC), time to maximum concentration (Tmax), maximum plasma drug concentration (Cmax), time to ROSC, and mean concentrations over time in a hypovolemic cardiac arrest model." | 7.83 | Effects of humerus intraosseous versus intravenous amiodarone administration in a hypovolemic porcine model. ( Adams, LT; Benham, BE; Bragdon, LG; Garcia-Blanco, JC; Green, LR; Holloway, CM; Johnson, D; Jurina, CS; Orszag, CJ, 2016) |
| "This study compared the effects of amiodarone via tibial intraosseous (TIO) and intravenous (IV) routes on return of spontaneous circulation (ROSC), time to ROSC, maximum drug concentration (Cmax), time to maximum concentration (Tmax), and mean concentrations over time in a hypovolemic cardiac arrest model." | 7.83 | The effects of tibial intraosseous versus intravenous amiodarone administration in a hypovolemic cardiac arrest procine model. ( Argame, JI; Bateman, T; Craig, W; Hampton, K; Johnson, D; Wang, E, 2016) |
| "The purpose of the experiment was to compare the effects of nifekalant and amiodarone on the return of spontaneous circulation (ROSC), survival, as well as on the hemodynamic parameters in a swine model of prolonged ventricular fibrillation (VF)." | 7.81 | Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation. ( Iacovidou, N; Karlis, G; Lelovas, P; Mentzelopoulos, S; Niforopoulou, P; Papalois, A; Siafaka, I; Xanthos, T, 2015) |
| "To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 7.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
| "To compare the early postarrest inflammatory cytokine response between animals administered amiodarone (AMIO) and lidocaine (LIDO) intra-arrest during resuscitation from ventricular fibrillation (VF)." | 7.79 | Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. ( Niemann, JT; Rosborough, JP; Shah, AP; Thomas, JL; Youngquist, ST, 2013) |
| " The patient was under amiodarone and sotalol therapy for atrial fibrillation, with no obvious QT prolongation prior to ciprofloxacin therapy." | 7.75 | Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. ( Arnaoutoglou, C; Chrisopoulos, C; Keivanidou, A; Kirpizidis, C; Krommydas, A; Papanikolaou, G; Tsiptses, K, 2009) |
| "Amiodarone has been shown to be superior to both placebo and lidocaine in improving survival to hospital admission for victims of out-of-hospital refractory ventricular fibrillation." | 7.72 | Effect of amiodarone on haemodynamics during cardiopulmonary resuscitation in a canine model of resistant ventricular fibrillation. ( Berg, RA; Cardoso, LF; Kern, KB; Paiva, EF; Perondi, MB; Ramirez, JA; Timerman, S, 2003) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 7.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Thirty-three consecutively referred patients with cardiac arrest from ventricular arrhythmias unassociated with a new acute myocardial infarction (AMI) were commenced on amiodarone therapy and followed for a minimum of 12 months." | 7.67 | Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1984) |
| "Multivariate analysis of 11 clinical variables was performed in 104 patients with sustained, symptomatic ventricular tachycardia (VT) or ventricular fibrillation treated with amiodarone to determine variables predictive of subsequent cardiac arrest or sudden death." | 7.67 | Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. ( Davis, JC; DiCarlo, LA; Evans-Bell, T; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Winston, SA, 1985) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 7.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more precordial shocks were randomly assigned to receive 300 mg of intravenous amiodarone (246 patients) or placebo (258 patients)." | 6.69 | Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. ( Cobb, LA; Copass, MK; Cummins, RO; Doherty, AM; Fahrenbruch, CE; Hallstrom, AP; Kudenchuk, PJ; Murray, WA; Olsufka, M; Walsh, T, 1999) |
| "Swine were anesthetized and placed into cardiac arrest." | 5.43 | The effects of sternal intraosseous and intravenous administration of amiodarone in a hypovolemic swine cardiac arrest model. ( Annelin, J; Borgkvist, B; Johnson, D; Kist, T; Long, R; Smith, S, 2016) |
| "In Japan, intravenous nifekalant (NIF) was often used for direct current cardioversion-resistant ventricular fibrillation (VF), until the use of intravenous amiodarone (AMD) was approved in 2007." | 5.14 | Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. ( Akieda, K; Amino, M; Fujibayashi, D; Fukushima, T; Hashida, T; Higami, S; Inokuchi, S; Kodama, I; Morita, S; Opthof, T; Otsuka, H; Shima, M; Tamura, K; Tanabe, T; Uemura, S; Yoshioka, K, 2010) |
| "As compared with lidocaine, amiodarone leads to substantially higher rates of survival to hospital admission in patients with shock-resistant out-of-hospital ventricular fibrillation." | 5.10 | Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. ( Barr, A; Cass, D; Cooper, R; Dorian, P; Gelaznikas, R; Schwartz, B, 2002) |
| "This study was undertaken to determine the association between amiodarone therapy and risk of complications of cardiac surgery in patients in the randomized placebo-controlled, double-blind Canadian Amiodarone Myocardial Infarction Arrhythmia Trial." | 5.10 | Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). ( Cairns, JA; Connolly, SJ; Crystal, E; Dorian, P; Gent, M; Kahn, S; Roberts, R; Thorpe, K, 2003) |
| "The Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) study evaluated antiarrhythmic drug treatment of survivors of out-of-hospital ventricular fibrillation (VF) not associated with a Q-wave myocardial infarction who were at especially high risk of recurrence of VF." | 5.07 | Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. ( , 1993) |
| "The Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) study evaluated antiarrhythmic drug therapy in patients who had survived an episode of out-of-hospital ventricular fibrillation (VF) and who were thought to be at high risk for recurrence of VF." | 5.07 | The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators. ( Greene, HL, 1993) |
| " In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, randomized trial, was initiated to compare metoprolol, amiodarone, propafenone, and ICD implantation in patients surviving sudden cardiac death due to documented ventricular tachycardia and/or ventricular fibrillation." | 5.07 | Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. ( Cappato, R; Kuck, KH; Rüppel, R; Schneider, MA; Siebels, J, 1993) |
| "We identified three articles addressing lidocaine versus amiodarone in cardiac arrest: 1) a prospective study assessing lidocaine versus amiodarone for refractory ventricular fibrillation in out-of-hospital adults; 2) an observational retrospective cohort study of inpatient pediatric patients with ventricular fibrillation or pulseless ventricular tachycardia who received lidocaine, amiodarone, neither or both; and 3) a prospective study of ventricular tachycardia with a pulse in adults." | 4.95 | Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review. ( Atkins, DL; De Caen, AR; Lopez-Herce, J; Marino, BS; McBride, ME; Webster, G; Ziegler, CP, 2017) |
| "We conducted a literature review between 1990 and 2006 in MEDLINE using the following MeSH headings: swine, dogs, resuscitation, heart arrest, EMS, EMT, ambulance, ventricular fibrillation, drug therapy, epinephrine, vasopressin, amiodarone, lidocaine, magnesium, and sodium bicarbonate." | 4.84 | Drug administration in animal studies of cardiac arrest does not reflect human clinical experience. ( Menegazzi, JJ; Reynolds, JC; Rittenberger, JC, 2007) |
| "Biphasic defibrillation and intravenous amiodarone are useful in shock-resistant ventricular fibrillation." | 4.82 | Strategies for reversing shock-resistant ventricular fibrillation. ( Dorian, P; Sarkozy, A, 2003) |
| " A second prospective, randomized clinical trial of amiodarone for refractory ventricular fibrillation has again shown positive results in improving survival to hospital admission." | 4.82 | Cardiopulmonary Resuscitation Guidelines 2000 update: what's happened since? ( Kern, KB; Xavier, LC, 2003) |
| "Amiodarone, an anti-ischaemic and anti-arrhythmic drug, has been the object of numerous studies and seems to be highly effective in the treatment of severe ventricular arrhythmias on dilated cardiomyopathies, as well as of hypertrophic or ischaemic heart diseases." | 4.78 | [Does amiodarone have a benefit effect on mortality?]. ( Kahn, JC; Pathé, M, 1991) |
| "To describe the successful management of ventricular fibrillation (VF) and ventricular tachycardia (VT) using cardiopulmonary resuscitation, including defibrillation, followed by continuous rate infusion of IV amiodarone, in a cat with cardiac arrest secondary to tachyarrhythmia." | 3.96 | Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat. ( Berlin, N; Kelmer, E; Maiorkis, I; Ohad, DG, 2020) |
| "To determine the association between amiodarone or lidocaine and outcomes in adult in-hospital cardiac arrest (IHCA) with shock-refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT)." | 3.96 | Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia. ( Chang, WT; Chen, WJ; Huang, CH; Liu, YB; Tsai, MS; Wang, CH; Wu, YW; Yu, PH, 2020) |
| "We describe a case of amiodarone-induced thyrotoxicosis (AIT) with cardiopulmonary arrest (CPA) in a 49-year-old woman." | 3.88 | Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest. ( Hasegawa, N; Inoue, K; Kakuta, Y; Kondo, T; Kowase, S; Miki, K; Nishikawa, T; Omura, M; Saito, J; Sugisawa, C; Tsurutani, Y, 2018) |
| "This study compared the effects of amiodarone via tibial intraosseous (TIO) and intravenous (IV) routes on return of spontaneous circulation (ROSC), time to ROSC, maximum drug concentration (Cmax), time to maximum concentration (Tmax), and mean concentrations over time in a hypovolemic cardiac arrest model." | 3.83 | The effects of tibial intraosseous versus intravenous amiodarone administration in a hypovolemic cardiac arrest procine model. ( Argame, JI; Bateman, T; Craig, W; Hampton, K; Johnson, D; Wang, E, 2016) |
| "To compare the effects of amiodarone administration by humerus intraosseous (HIO) and intravenous (IV) routes on return of spontaneous circulation (ROSC), time to maximum concentration (Tmax), maximum plasma drug concentration (Cmax), time to ROSC, and mean concentrations over time in a hypovolemic cardiac arrest model." | 3.83 | Effects of humerus intraosseous versus intravenous amiodarone administration in a hypovolemic porcine model. ( Adams, LT; Benham, BE; Bragdon, LG; Garcia-Blanco, JC; Green, LR; Holloway, CM; Johnson, D; Jurina, CS; Orszag, CJ, 2016) |
| "The purpose of the experiment was to compare the effects of nifekalant and amiodarone on the return of spontaneous circulation (ROSC), survival, as well as on the hemodynamic parameters in a swine model of prolonged ventricular fibrillation (VF)." | 3.81 | Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation. ( Iacovidou, N; Karlis, G; Lelovas, P; Mentzelopoulos, S; Niforopoulou, P; Papalois, A; Siafaka, I; Xanthos, T, 2015) |
| "To determine the association between amiodarone and lidocaine and outcomes in children with cardiac arrest with pulseless ventricular tachycardia (pVT) and ventricular fibrillation (VF)." | 3.80 | Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. ( Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO, 2014) |
| " We present the case of 52-year-old male who was treated with clarithromycin due to bilateral atypical pneumonia." | 3.80 | Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment. ( Bienias, P; Ciurzyński, M; Paczyńska, M; Pruszczyk, P, 2014) |
| "To compare the early postarrest inflammatory cytokine response between animals administered amiodarone (AMIO) and lidocaine (LIDO) intra-arrest during resuscitation from ventricular fibrillation (VF)." | 3.79 | Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. ( Niemann, JT; Rosborough, JP; Shah, AP; Thomas, JL; Youngquist, ST, 2013) |
| "To characterize the frequency and type of cardiac events, including torsade de pointes, associated with dronedarone and its structural analog, amiodarone, outside of the clinical trial setting." | 3.78 | Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting. ( Hiatt, WR; Kao, DP; Krantz, MJ, 2012) |
| "After 4min of untreated ventricular fibrillation, animals were randomly treated with nifekalant (2mgkg(-1)), amiodarone (5mgkg(-1)) or saline placebo (n=12 pigs per group)." | 3.76 | Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest. ( Cong, LH; Ji, XF; Li, CS; Wang, S; Yang, L, 2010) |
| "Accidental intravascular administration of bupivacaine during performance of a brachial block precipitated convulsions followed by asystole." | 3.75 | Recurrence of cardiotoxicity after lipid rescue from bupivacaine-induced cardiac arrest. ( Coetzee, AR; Levin, AI; Marwick, PC, 2009) |
| " The patient was under amiodarone and sotalol therapy for atrial fibrillation, with no obvious QT prolongation prior to ciprofloxacin therapy." | 3.75 | Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. ( Arnaoutoglou, C; Chrisopoulos, C; Keivanidou, A; Kirpizidis, C; Krommydas, A; Papanikolaou, G; Tsiptses, K, 2009) |
| "Although amiodarone significantly increases survival to hospital admission when used in resuscitation of out-of-hospital pulseless ventricular tachycardia and fibrillation, there are limited data on its utility for in-hospital arrests." | 3.73 | The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres. ( Al-Hazmi, A; Martin, J; Pollak, PT; Wee, V; Zarnke, KB, 2006) |
| "Data from this experimental animal model suggest that vasopressin and amiodarone may not be beneficial for treatment of ventricular fibrillation associated with severe hypothermia when concomitant measures at core rewarming are not applied." | 3.72 | Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest. ( Girg, S; Lindner, KH; Mair, P; Schwarz, B; Stadlbauer, KH; Wagner-Berger, H; Wenzel, V, 2003) |
| "Amiodarone has been shown to be superior to both placebo and lidocaine in improving survival to hospital admission for victims of out-of-hospital refractory ventricular fibrillation." | 3.72 | Effect of amiodarone on haemodynamics during cardiopulmonary resuscitation in a canine model of resistant ventricular fibrillation. ( Berg, RA; Cardoso, LF; Kern, KB; Paiva, EF; Perondi, MB; Ramirez, JA; Timerman, S, 2003) |
| "The aim of this study was to evaluate the survival of patients with hypertrophic cardiomyopathy (HCM) after resuscitated ventricular fibrillation or syncopal sustained ventricular tachycardia (VT/VF) when treated with low dose amiodarone or implantable cardioverter defibrillators (ICDs)." | 3.70 | Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. ( Elliott, PM; McKenna, WJ; Poloniecki, J; Rowland, E; Sharma, S; Varnava, A, 1999) |
| "Torsade de pointes may occur as a complication of amiodarone therapy." | 3.68 | Sudden cardiac death while taking amiodarone therapy: the role of abnormal repolarization. ( Lopes, A; Morgan, JM; Rowland, E, 1991) |
| "Thirty-three consecutively referred patients with cardiac arrest from ventricular arrhythmias unassociated with a new acute myocardial infarction (AMI) were commenced on amiodarone therapy and followed for a minimum of 12 months." | 3.67 | Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. ( Hamer, A; Mandel, WJ; Peter, T; Weiss, D, 1984) |
| "In order to assess the long-term efficacy of amiodarone, we followed 187 survivors of cardiac arrest and 316 patients with nonsustained or sustained ventricular tachycardia and compared the results of amiodarone therapy with the results of conventional therapy." | 3.67 | Long-term results of amiodarone therapy. ( Herre, JM; Sauve, MJ; Scheinman, MM, 1987) |
| "During treatment with amiodarone, digoxin and nadolol, asystole occurred repeatedly in a patient with chronic persistent automatic atrial tachycardia." | 3.67 | Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia. ( Kuo, CS; Paciotti, MV; Reddy, CP, 1985) |
| "Multivariate analysis of 11 clinical variables was performed in 104 patients with sustained, symptomatic ventricular tachycardia (VT) or ventricular fibrillation treated with amiodarone to determine variables predictive of subsequent cardiac arrest or sudden death." | 3.67 | Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. ( Davis, JC; DiCarlo, LA; Evans-Bell, T; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Winston, SA, 1985) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 3.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Patients who had cardiac arrest with ventricular fibrillation (or pulseless ventricular tachycardia) and who had not been resuscitated after receiving three or more precordial shocks were randomly assigned to receive 300 mg of intravenous amiodarone (246 patients) or placebo (258 patients)." | 2.69 | Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. ( Cobb, LA; Copass, MK; Cummins, RO; Doherty, AM; Fahrenbruch, CE; Hallstrom, AP; Kudenchuk, PJ; Murray, WA; Olsufka, M; Walsh, T, 1999) |
| "Most studies of cardiac arrest report outcome following out-of-hospital resuscitation." | 2.69 | In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators. ( Cannom, DS; Epstein, AE; Greene, HL; Herre, JM; Lancaster, S; Ocampo, C; Powell, J; Rosenberg, Y; Yao, Q, 1999) |
| "During long-term follow-up of cardiac arrest survivors, therapy with an ICD is associated with a 23% (nonsignificant) reduction of all-cause mortality rates when compared with treatment with amiodarone/metoprolol." | 2.69 | Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). ( Cappato, R; Kuck, KH; Rüppel, R; Siebels, J, 2000) |
| "In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, multicenter, randomized controlled study, was started in survivors of sudden cardiac death resulting from documented ventricular tachyarrhythmias." | 2.67 | Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). ( Kuck, KH; Siebels, J, 1994) |
| "Amiodarone is an antiarrhythmic medication used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias." | 2.47 | Amiodarone supplants lidocaine in ACLS and CPR protocols. ( Camporesi, EM; Mangar, D; Mizzi, A; Tran, T, 2011) |
| "In connection with prehospital cardiac arrest, early defibrillation is particularly important, including the widespread availability of (semi)automatic defibrillators." | 2.43 | [Resuscitation after prehospital cardiovascular arrest]. ( Fichtlscherer, S; Klingenheben, T; Zeiher, AM, 2005) |
| "Patients with symptomatic ventricular tachycardia, ventricular fibrillation, or aborted sudden cardiac death remain at high risk for arrhythmia recurrence." | 2.40 | Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest. ( Borggrefe, M; Breithardt, G; Eckardt, L; Haverkamp, W, 1997) |
| "Amiodarone was given in 30." | 1.56 | Frequency of Advanced Cardiac Life Support Medication Use and Association With Survival During In-hospital Cardiac Arrest. ( Ahn, J; Benz, P; Brenner, N; Chong, S; Dubin, J; Goyal, M; Heinrichs, D; Titus, S; Wilson, M; Woo, S, 2020) |
| "Cardiac arrest affects more than 500 000 people every year, with significant associated morbidity and mortality." | 1.56 | Decreasing the Stress of Medication Management During Cardiac Arrest. ( Perriello, E; Teevan, C, 2020) |
| "Early medication administration in cardiac arrest improves outcomes." | 1.56 | Retrospective evaluation of resuscitation medication utilization in hospitalized adult patients with cardiac arrest. ( Hung, KKC; Lam, RPK; Lee, RHY; Tenney, JW; Wong, BCY; Wong, DKW; Wong, WT; Yip, JHY, 2020) |
| "Adult in-hospital cardiac arrest patients." | 1.51 | Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest. ( Andersen, LW; Berg, KM; Donnino, MW; Grossestreuer, AV; Moskowitz, A; Ross, CE, 2019) |
| "Swine were anesthetized and placed into cardiac arrest." | 1.43 | The effects of sternal intraosseous and intravenous administration of amiodarone in a hypovolemic swine cardiac arrest model. ( Annelin, J; Borgkvist, B; Johnson, D; Kist, T; Long, R; Smith, S, 2016) |
| "Survival after out-of-hospital cardiac arrest (OHCA) remains poor." | 1.40 | Early coronary revascularization improves 24h survival and neurological function after ischemic cardiac arrest. A randomized animal study. ( Caldwell, E; Garcia, S; Henry, P; Lurie, K; Magkoutis, N; McKnite, S; Rees, J; Sarraf, M; Sharma, A; Sideris, G; Yannopoulos, D, 2014) |
| "Arrhythmogenic right ventricular cardiomyopathy is a desmosomal disease." | 1.37 | Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. ( Smith, W, 2011) |
| "Patients at risk of cardiac arrest should be identified and preventative action taken." | 1.37 | [Update on current care guidelines: resuscitation]. ( , 2011) |
| "Caffeine is a natural alkaloid methylxanthine that is found in various plants such as coffee or tea." | 1.36 | A case of fatal caffeine poisoning. ( Knudsen, K; Rudolph, T, 2010) |
| "Sustained monomorphic ventricular tachycardia was defined as a tachycardia with uninterrupted duration or rapid recurrence despite automatic internal cardiac defibrillator therapy for at least 5 minutes before amiodarone treatment, monomorphic morphology, rate greater than 120 beats/min, QRS duration greater than 120 ms, and subsequently determined to be ventricular tachycardia by ECG criteria (eg, atrioventricular dissociation), implanted device interrogation, or formal electrophysiology study." | 1.33 | Amiodarone is poorly effective for the acute termination of ventricular tachycardia. ( deSouza, IS; Marill, KA; Nishijima, DK; Ruskin, JN; Setnik, GS; Stair, TO, 2006) |
| " Inadequate dosing and later administration of amiodarone in the code were two confounding factors in this study." | 1.33 | Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. ( Henderson, SO; Idrees, U; Kane-Gill, SL; Kirisci, L; Ou, NN; Oyen, LJ; Rea, RS; Rudis, MI; Seybert, AL; Stauss, JL, 2006) |
| "We report a case of a patient with paroxysmal atrial fibrillation (PAF) and with a permanent AAIR (bipolar atrial-inhibited adaptive rate) pacemaker who suffered life-threatening episodes of arrhythmias during operation." | 1.33 | Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery. ( Borel, CO; Lin, JA; Wang, WB; Wong, CS; Wu, CT; Yang, CP; Yeh, CC, 2006) |
| "Amiodarone has been associated with side-effects and difficulty of administration, due to recommended dilution, rendering it suboptimal for out-of-hospital cardiac arrest (CA) management." | 1.32 | The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. ( Boyd, J; Castren, M; Kuisma, M; Määttä, T; Repo, J; Rosenberg, PH; Skrifvars, MB, 2004) |
| "Concerning the haemodynamic agents for cardiac arrest, the efficacy of high doses of adrenalin is not greater than with conventional doses." | 1.32 | [Changes in the management of cardiac arrest]. ( Genest, M; Pochmalicki, G, 2004) |
| "Sudden cardiac arrest survivors have a high risk of suffering from recurrent arrhythmic events." | 1.32 | Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy. ( Hennersdorf, MG; Niebch, V; Perings, C; Strauer, BE; Vester, EG; Winter, J, 2003) |
| "Recurrent ventricular fibrillation was observed in a 29-year-old Vietnamese man who did not exhibit structural heart disease." | 1.31 | Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant? ( Kalla, H; Marinchak, R; Yan, GX, 2000) |
| "Surprisingly, arrhythmia recurrence rates were not significantly different by the method of determining an efficacy prediction." | 1.29 | Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management. ( Anderson, JL, 1995) |
| "A case of exercise-induced cardiac arrest secondary to catecholamine-sensitive right ventricular tachycardia in the absence of apparent structural heart disease is presented." | 1.28 | Catecholamine-sensitive right ventricular tachycardia in the absence of structural heart disease: a mechanism of exercise-induced cardiac arrest. ( Nadamanee, K; Taylor, R; Wesley, RC, 1991) |
| " Furthermore, amiodarone may interact with beta-blocking agents and some of the calcium antagonists to produce symptomatic sinus bradycardia and sinus arrest, especially in a latent or overt sick sinus syndrome." | 1.27 | Drug interactions with amiodarone. ( Marcus, FI, 1983) |
| " The latter, however, was taking antiarrhythmic drugs at a dosage less than that proved to be effective during electropharmacological testing." | 1.27 | [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. ( Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1984) |
| "A patient with clinically silent mitral valve prolapse experienced an episode of out-of-hospital cardiac arrest due to ventricular fibrillation." | 1.27 | Ventricular fibrillation in a patient with 'silent' mitral valve prolapse. ( Agmon, J; Caspi, A; Kusniec, J; Lewin, RF; Sclarovsky, S; Strasberg, B, 1988) |
| "Ventricular arrhythmias could be induced in 69% of patients with aborted sudden death but inducibility could be suppressed in only 20% of them." | 1.27 | Electrophysiologic testing and follow-up of patients with aborted sudden death. ( Eldar, M; Sauve, MJ; Scheinman, MM, 1987) |
| "Amiodarone was used for recurrent supraventricular tachycardia in four cases and frequent ventricular extra systoles complicating congenital QT prolongation in the remaining case." | 1.27 | Amiodarone-induced torsades de pointes. ( Brown, MA; Lubbe, WF; Norris, RM; Smith, WM, 1986) |
| "In the MVP group, the following arrhythmias were induced: nonsustained polymorphic VT in 10, VF in three, and ventricular flutter in one." | 1.27 | The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias. ( Gang, ES; Hamer, A; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (17.39) | 18.7374 |
| 1990's | 29 (18.01) | 18.2507 |
| 2000's | 46 (28.57) | 29.6817 |
| 2010's | 46 (28.57) | 24.3611 |
| 2020's | 12 (7.45) | 2.80 |
| Authors | Studies |
|---|---|
| Corazza, F | 1 |
| Fiorese, E | 1 |
| Arpone, M | 1 |
| Tardini, G | 1 |
| Frigo, AC | 1 |
| Cheng, A | 1 |
| Da Dalt, L | 1 |
| Bressan, S | 1 |
| Wang, Q | 1 |
| Lin, Z | 1 |
| Chen, H | 1 |
| Pan, B | 1 |
| Murphy, TW | 1 |
| Kadir, S | 1 |
| Benz, P | 1 |
| Chong, S | 1 |
| Woo, S | 1 |
| Brenner, N | 1 |
| Wilson, M | 1 |
| Dubin, J | 1 |
| Heinrichs, D | 1 |
| Titus, S | 1 |
| Ahn, J | 1 |
| Goyal, M | 1 |
| Tenney, JW | 1 |
| Yip, JHY | 1 |
| Lee, RHY | 1 |
| Wong, BCY | 1 |
| Hung, KKC | 1 |
| Lam, RPK | 1 |
| Wong, DKW | 1 |
| Wong, WT | 1 |
| Berlin, N | 1 |
| Ohad, DG | 1 |
| Maiorkis, I | 1 |
| Kelmer, E | 1 |
| Zhao, H | 2 |
| Fan, K | 2 |
| Feng, G | 2 |
| Teevan, C | 1 |
| Perriello, E | 1 |
| deSouza, IS | 2 |
| Allen, R | 1 |
| Thode, HC | 1 |
| Meyer-Szary, J | 1 |
| Gasecka, A | 1 |
| John, I | 1 |
| Jaguszewski, MJ | 1 |
| Peacock, FW | 1 |
| Gilis-Malinowska, N | 1 |
| Szarpak, L | 1 |
| Contou, D | 1 |
| Lecronier, M | 1 |
| Urbina, T | 1 |
| de Prost, N | 1 |
| Fritock, MD | 1 |
| Ing, RJ | 1 |
| Twite, MD | 1 |
| Inoue, K | 1 |
| Saito, J | 1 |
| Kondo, T | 1 |
| Miki, K | 1 |
| Sugisawa, C | 1 |
| Tsurutani, Y | 1 |
| Hasegawa, N | 1 |
| Kowase, S | 1 |
| Kakuta, Y | 1 |
| Omura, M | 1 |
| Nishikawa, T | 1 |
| Eberl, M | 1 |
| Seidel, M | 1 |
| Li, XM | 1 |
| Ge, HY | 1 |
| Liu, XQ | 1 |
| Shi, L | 1 |
| Guo, BJ | 1 |
| Li, MT | 1 |
| Jiang, H | 1 |
| Zhang, Y | 1 |
| Liu, HJ | 1 |
| Zheng, XC | 1 |
| Li, AJ | 1 |
| Zhang, YY | 1 |
| Cerrato, N | 1 |
| Calzolari, G | 1 |
| Tizzani, P | 1 |
| Actis Perinetto, E | 1 |
| Dellavalle, A | 1 |
| Aluffi, E | 1 |
| Moskowitz, A | 1 |
| Ross, CE | 1 |
| Andersen, LW | 1 |
| Grossestreuer, AV | 1 |
| Berg, KM | 2 |
| Donnino, MW | 2 |
| Soar, J | 1 |
| Perkins, GD | 1 |
| Maconochie, I | 1 |
| Böttiger, BW | 1 |
| Deakin, CD | 1 |
| Sandroni, C | 1 |
| Olasveengen, TM | 1 |
| Wyllie, J | 1 |
| Greif, R | 1 |
| Lockey, A | 1 |
| Semeraro, F | 1 |
| Van de Voorde, P | 1 |
| Lott, C | 1 |
| Bossaert, L | 1 |
| Monsieurs, KG | 1 |
| Nolan, JP | 1 |
| Yamanaka, K | 1 |
| Inoue, S | 1 |
| Rodriguez-Rodriguez, A | 1 |
| Boyero, L | 1 |
| Sempere, L | 1 |
| Vilches-Arenas, A | 1 |
| Panchal, AR | 1 |
| Kudenchuk, PJ | 4 |
| Del Rios, M | 1 |
| Hirsch, KG | 1 |
| Link, MS | 1 |
| Kurz, MC | 1 |
| Chan, PS | 1 |
| Cabañas, JG | 1 |
| Morley, PT | 1 |
| Hazinski, MF | 1 |
| Wang, CH | 1 |
| Chang, WT | 1 |
| Huang, CH | 1 |
| Tsai, MS | 1 |
| Yu, PH | 1 |
| Wu, YW | 1 |
| Liu, YB | 1 |
| Chen, WJ | 1 |
| Riaz, A | 1 |
| Hieb, H | 1 |
| Foley, B | 1 |
| Mulvihill, N | 1 |
| Crean, P | 1 |
| Murphy, RT | 1 |
| Daly, C | 1 |
| Boyle, N | 1 |
| Glover, BM | 1 |
| Hu, X | 1 |
| Aves, T | 1 |
| Ramadeen, A | 1 |
| Zou, L | 1 |
| Leong-Poi, H | 1 |
| Fujii, H | 1 |
| Dorian, P | 8 |
| Haraldsdottir, S | 1 |
| Li, Q | 1 |
| Villalona-Calero, MA | 1 |
| Olencki, TE | 1 |
| Kendra, K | 1 |
| Ing, SW | 1 |
| Youngquist, ST | 1 |
| Niemann, JT | 1 |
| Shah, AP | 1 |
| Thomas, JL | 1 |
| Rosborough, JP | 1 |
| Botha, M | 1 |
| Wells, M | 1 |
| Dickerson, R | 1 |
| Wallis, L | 1 |
| Stander, M | 1 |
| Sideris, G | 1 |
| Magkoutis, N | 1 |
| Sharma, A | 1 |
| Rees, J | 1 |
| McKnite, S | 1 |
| Caldwell, E | 1 |
| Sarraf, M | 1 |
| Henry, P | 1 |
| Lurie, K | 1 |
| Garcia, S | 1 |
| Yannopoulos, D | 1 |
| Karlis, G | 3 |
| Iacovidou, N | 2 |
| Lelovas, P | 2 |
| Niforopoulou, P | 2 |
| Zacharioudaki, A | 1 |
| Papalois, A | 2 |
| Sunde, K | 1 |
| Steen, PA | 1 |
| Xanthos, T | 3 |
| Valdes, SO | 1 |
| Donoghue, AJ | 1 |
| Hoyme, DB | 1 |
| Hammond, R | 1 |
| Berg, MD | 1 |
| Berg, RA | 2 |
| Samson, RA | 1 |
| Semenas, E | 2 |
| Sharma, HS | 1 |
| Wiklund, L | 1 |
| Zoerner, F | 1 |
| Bienias, P | 1 |
| Ciurzyński, M | 1 |
| Paczyńska, M | 1 |
| Pruszczyk, P | 1 |
| Engdahl, J | 1 |
| Hollenberg, J | 1 |
| Rubertsson, S | 1 |
| Holmgren, C | 1 |
| Rosenqvist, M | 1 |
| Siafaka, I | 1 |
| Mentzelopoulos, S | 1 |
| Merefield, DC | 1 |
| Beckham, J | 1 |
| Laina, A | 1 |
| Liakos, A | 1 |
| Georgiopoulos, G | 1 |
| Oikonomou, D | 1 |
| Kouskouni, E | 1 |
| Chalkias, A | 1 |
| Daya, M | 1 |
| Pollak, PT | 2 |
| Spence, JD | 1 |
| Patel, JJ | 1 |
| Rosini, JM | 1 |
| Zizza, L | 1 |
| Hunter, BR | 1 |
| Musey, PI | 1 |
| McBride, ME | 1 |
| Marino, BS | 1 |
| Webster, G | 1 |
| Lopez-Herce, J | 1 |
| Ziegler, CP | 1 |
| De Caen, AR | 1 |
| Atkins, DL | 1 |
| O'Sullivan, M | 1 |
| Martinez, A | 1 |
| Long, A | 1 |
| Johnson, M | 1 |
| Blouin, D | 1 |
| Johnson, AD | 1 |
| Burgert, JM | 1 |
| Hampton, K | 1 |
| Wang, E | 1 |
| Argame, JI | 1 |
| Bateman, T | 1 |
| Craig, W | 1 |
| Johnson, D | 3 |
| Smith, S | 1 |
| Borgkvist, B | 1 |
| Kist, T | 1 |
| Annelin, J | 1 |
| Long, R | 1 |
| Holloway, CM | 1 |
| Jurina, CS | 1 |
| Orszag, CJ | 1 |
| Bragdon, LG | 1 |
| Green, LR | 1 |
| Garcia-Blanco, JC | 1 |
| Benham, BE | 1 |
| Adams, LT | 1 |
| Leeuwenburgh, BP | 1 |
| Versteegh, MI | 1 |
| Maas, JJ | 1 |
| Dunning, J | 1 |
| Kalimullah, EA | 1 |
| Bryant, SM | 1 |
| Marwick, PC | 1 |
| Levin, AI | 1 |
| Coetzee, AR | 1 |
| Keivanidou, A | 1 |
| Arnaoutoglou, C | 1 |
| Krommydas, A | 1 |
| Papanikolaou, G | 1 |
| Tsiptses, K | 1 |
| Chrisopoulos, C | 1 |
| Kirpizidis, C | 1 |
| Rudolph, T | 1 |
| Knudsen, K | 1 |
| Amino, M | 1 |
| Yoshioka, K | 1 |
| Opthof, T | 1 |
| Morita, S | 1 |
| Uemura, S | 1 |
| Tamura, K | 1 |
| Fukushima, T | 1 |
| Higami, S | 1 |
| Otsuka, H | 1 |
| Akieda, K | 1 |
| Shima, M | 1 |
| Fujibayashi, D | 1 |
| Hashida, T | 1 |
| Inokuchi, S | 1 |
| Kodama, I | 1 |
| Tanabe, T | 1 |
| Ji, XF | 1 |
| Li, CS | 1 |
| Wang, S | 1 |
| Yang, L | 1 |
| Cong, LH | 1 |
| Li, J | 1 |
| Zitron, E | 1 |
| Katus, HA | 1 |
| Becker, R | 1 |
| Tritakarn, T | 1 |
| Teeratchanan, T | 1 |
| Boyd, T | 1 |
| Brady, W | 1 |
| Mizzi, A | 1 |
| Tran, T | 1 |
| Mangar, D | 1 |
| Camporesi, EM | 1 |
| Smith, W | 1 |
| Kao, DP | 1 |
| Hiatt, WR | 1 |
| Krantz, MJ | 1 |
| Silfvast, T | 1 |
| Pettilä, V | 1 |
| Hsu, J | 1 |
| Uratsu, C | 1 |
| Truman, A | 1 |
| Quesenberry, C | 1 |
| McDonald, KM | 1 |
| Hlatky, MA | 1 |
| Selby, J | 1 |
| Seniuk, W | 1 |
| Mularek-Kubzdela, T | 1 |
| Grygier, M | 1 |
| Grajek, S | 1 |
| Cieśliński, A | 1 |
| Willan, AR | 3 |
| Chen, EB | 1 |
| Cook, RJ | 1 |
| Lin, DY | 3 |
| Emori, T | 1 |
| Ohta, K | 1 |
| Kusano, K | 1 |
| Morita, H | 1 |
| Matsubara, H | 1 |
| Sano, S | 1 |
| Ohe, T | 1 |
| Crystal, E | 1 |
| Kahn, S | 1 |
| Roberts, R | 2 |
| Thorpe, K | 1 |
| Gent, M | 2 |
| Cairns, JA | 1 |
| Connolly, SJ | 3 |
| Moulik, PK | 1 |
| Attar, MN | 1 |
| Rose, EL | 1 |
| Khaleeli, AA | 1 |
| Sarkozy, A | 1 |
| Xavier, LC | 1 |
| Kern, KB | 2 |
| Hennersdorf, MG | 1 |
| Niebch, V | 1 |
| Vester, EG | 1 |
| Winter, J | 1 |
| Perings, C | 1 |
| Strauer, BE | 1 |
| Franks, AM | 1 |
| Watterson, KS | 1 |
| Paiva, EF | 1 |
| Perondi, MB | 1 |
| Timerman, S | 1 |
| Cardoso, LF | 1 |
| Ramirez, JA | 1 |
| Schwarz, B | 1 |
| Mair, P | 1 |
| Wagner-Berger, H | 1 |
| Stadlbauer, KH | 1 |
| Girg, S | 1 |
| Wenzel, V | 1 |
| Lindner, KH | 1 |
| Arxer, A | 1 |
| Novoa, L | 1 |
| Vieito Amor, M | 1 |
| Hernández Iniesta, J | 1 |
| Villalonga, A | 1 |
| Ng, GY | 1 |
| Hampson Evans, DC | 1 |
| Murdoch, LJ | 1 |
| Sivasubramonian, S | 1 |
| Rosenthal, E | 1 |
| Cappato, R | 4 |
| Boczor, S | 1 |
| Kuck, KH | 5 |
| Skrifvars, MB | 1 |
| Kuisma, M | 1 |
| Boyd, J | 1 |
| Määttä, T | 1 |
| Repo, J | 1 |
| Rosenberg, PH | 1 |
| Castren, M | 1 |
| Genest, M | 1 |
| Pochmalicki, G | 1 |
| Manca, A | 1 |
| Hong, MF | 1 |
| Klingenheben, T | 1 |
| Zeiher, AM | 1 |
| Fichtlscherer, S | 1 |
| Marill, KA | 1 |
| Nishijima, DK | 1 |
| Stair, TO | 1 |
| Setnik, GS | 1 |
| Ruskin, JN | 3 |
| Wee, V | 1 |
| Al-Hazmi, A | 1 |
| Martin, J | 1 |
| Zarnke, KB | 1 |
| Abu-Laban, RB | 1 |
| Wira, C | 1 |
| Martin, G | 1 |
| Stoner, J | 1 |
| Margolis, K | 1 |
| Donnino, M | 1 |
| Rea, RS | 1 |
| Kane-Gill, SL | 1 |
| Rudis, MI | 1 |
| Seybert, AL | 1 |
| Oyen, LJ | 1 |
| Ou, NN | 1 |
| Stauss, JL | 1 |
| Kirisci, L | 1 |
| Idrees, U | 1 |
| Henderson, SO | 1 |
| Hohnloser, SH | 1 |
| Israel, CW | 1 |
| Fain, E | 1 |
| Champagne, J | 1 |
| Lin, JA | 1 |
| Borel, CO | 1 |
| Wang, WB | 1 |
| Wong, CS | 1 |
| Yeh, CC | 1 |
| Yang, CP | 1 |
| Wu, CT | 1 |
| Stockman, W | 1 |
| De Keyser, J | 1 |
| Brabant, S | 1 |
| Spoelders, K | 1 |
| Vuylsteke, P | 1 |
| Beeuwsaert, R | 1 |
| Coppé, E | 1 |
| Reynolds, JC | 1 |
| Rittenberger, JC | 1 |
| Menegazzi, JJ | 1 |
| Sinha, SK | 1 |
| Marcus, FI | 1 |
| Rossi, L | 1 |
| Raviele, A | 1 |
| Di Pede, F | 1 |
| Delise, P | 1 |
| Piccolo, E | 1 |
| Morady, F | 2 |
| Sauve, MJ | 4 |
| Malone, P | 2 |
| Shen, EN | 1 |
| Schwartz, AB | 1 |
| Bhandari, A | 1 |
| Keung, E | 1 |
| Sung, RJ | 1 |
| Scheinman, MM | 5 |
| Peter, T | 2 |
| Hamer, A | 2 |
| Weiss, D | 1 |
| Mandel, WJ | 2 |
| McGovern, B | 2 |
| Garan, H | 2 |
| Keidar, S | 1 |
| Grenadier, E | 1 |
| Palant, A | 1 |
| Southworth, W | 1 |
| Friday, KJ | 1 |
| Ruffy, R | 1 |
| Siebels, J | 4 |
| Rüppel, R | 3 |
| Schneider, MA | 2 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| Greene, HL | 2 |
| Stevenson, WG | 1 |
| Stevenson, LW | 1 |
| Middlekauff, HR | 1 |
| Saxon, LA | 1 |
| Anderson, JL | 1 |
| Martens, P | 1 |
| Vandekerckhove, Y | 1 |
| Muratore, C | 1 |
| Rabinovich, R | 1 |
| Iglesias, R | 1 |
| González, M | 1 |
| Darú, V | 1 |
| Liprandi, AS | 1 |
| Haverkamp, W | 1 |
| Eckardt, L | 1 |
| Borggrefe, M | 1 |
| Breithardt, G | 1 |
| Gómez-Barrado, JJ | 1 |
| García-Rubira, JC | 1 |
| Turégano Albarrán, S | 1 |
| Pavón García, M | 1 |
| Hidalgo Urbano, R | 1 |
| Montes Ramírez, JM | 1 |
| Cruz Fernández, JM | 1 |
| Frishman, WH | 1 |
| Vahdat, S | 1 |
| Bhatta, S | 1 |
| Domanski, MJ | 1 |
| Exner, DV | 1 |
| Trohman, RG | 1 |
| Sahu, J | 1 |
| Kavesh, NG | 1 |
| Olsovsky, MR | 1 |
| Freudenberger, RS | 1 |
| Conte, JV | 1 |
| Peters, RW | 1 |
| Shorofsky, SR | 1 |
| Gold, MR | 1 |
| Elliott, PM | 1 |
| Sharma, S | 1 |
| Varnava, A | 1 |
| Poloniecki, J | 1 |
| Rowland, E | 2 |
| McKenna, WJ | 1 |
| Cobb, LA | 1 |
| Copass, MK | 1 |
| Cummins, RO | 1 |
| Doherty, AM | 1 |
| Fahrenbruch, CE | 1 |
| Hallstrom, AP | 1 |
| Murray, WA | 1 |
| Olsufka, M | 1 |
| Walsh, T | 1 |
| Epstein, AE | 1 |
| Powell, J | 1 |
| Yao, Q | 1 |
| Ocampo, C | 1 |
| Lancaster, S | 1 |
| Rosenberg, Y | 1 |
| Cannom, DS | 1 |
| Herre, JM | 2 |
| Ballew, KA | 1 |
| Philbrick, JT | 1 |
| Shieh, JP | 1 |
| Chu, CC | 1 |
| Chen, JY | 1 |
| Chen, YH | 1 |
| Yeh, FC | 1 |
| Hsing, CH | 1 |
| Kalla, H | 1 |
| Yan, GX | 1 |
| Marinchak, R | 1 |
| Fogel, RI | 1 |
| Prystowsky, EN | 4 |
| Taylor, R | 2 |
| Racht, E | 1 |
| Caron, MF | 1 |
| White, CM | 1 |
| Cass, D | 1 |
| Schwartz, B | 1 |
| Cooper, R | 1 |
| Gelaznikas, R | 1 |
| Barr, A | 1 |
| Singh, BN | 1 |
| Derrida, JP | 1 |
| Ollagnier, J | 1 |
| Benaim, R | 1 |
| Haiat, R | 1 |
| Chiche, P | 1 |
| Knilans, TK | 1 |
| Wesley, RC | 1 |
| Nadamanee, K | 1 |
| Morgan, JM | 1 |
| Lopes, A | 1 |
| Pathé, M | 1 |
| Kahn, JC | 1 |
| Roden, DM | 1 |
| Williams, ML | 1 |
| Woelfel, A | 1 |
| Cascio, WE | 1 |
| Simpson, RJ | 1 |
| Gettes, LS | 1 |
| Foster, JR | 1 |
| Morganroth, J | 1 |
| Strasberg, B | 1 |
| Caspi, A | 1 |
| Kusniec, J | 1 |
| Lewin, RF | 1 |
| Sclarovsky, S | 1 |
| Agmon, J | 1 |
| Popławska, W | 1 |
| Chlewicka, I | 1 |
| Wójcik, E | 1 |
| Paczkowski, D | 1 |
| Walczak, F | 1 |
| Podleśny, J | 1 |
| Klein, HO | 1 |
| Beker, B | 1 |
| DiSegni, E | 1 |
| Kaplinsky, E | 1 |
| Eldar, M | 1 |
| Brown, MA | 1 |
| Smith, WM | 1 |
| Lubbe, WF | 1 |
| Norris, RM | 1 |
| Veltri, EP | 1 |
| Reid, PR | 1 |
| Kuo, CS | 1 |
| Reddy, CP | 1 |
| Paciotti, MV | 1 |
| Roy, D | 1 |
| Marchlinski, FE | 1 |
| Doherty, JU | 1 |
| Buxton, AE | 2 |
| Josephson, ME | 2 |
| Skale, BT | 1 |
| Miles, WM | 1 |
| Heger, JJ | 1 |
| Zipes, DP | 1 |
| DiCarlo, LA | 1 |
| Davis, JC | 1 |
| Evans-Bell, T | 1 |
| Winston, SA | 1 |
| Rosenthal, ME | 1 |
| Gang, ES | 1 |
| Oseran, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| An Investigation Into the Effects of Intravenous Lipid Emulsion (ILE) on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.[NCT02924454] | Phase 4 | 10 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| [NCT00257959] | Phase 4 | 400 participants | Interventional | 2001-01-31 | Completed | ||
| [NCT00000464] | Phase 3 | 0 participants | Interventional | 1987-04-30 | Completed | ||
| EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic CardioMyopathy[NCT03259113] | 30 participants (Anticipated) | Interventional | 2017-08-16 | Recruiting | |||
| [NCT00000531] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 reviews available for amiodarone and Heart Arrest
| Article | Year |
|---|---|
The impact of cognitive aids on resuscitation performance in in-hospital cardiac arrest scenarios: a systematic review and meta-analysis.
Topics: Adult; Amiodarone; Cardiopulmonary Resuscitation; Child; Heart Arrest; Hospitals; Humans; Thorax | 2022 |
Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: A network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2023 |
Amiodarone and/or lidocaine for cardiac arrest: A Bayesian network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Ana | 2020 |
Adrenaline and amiodarone dosages in resuscitation: rectifying misinformation.
Topics: Adrenergic alpha-Agonists; Amiodarone; Dose-Response Relationship, Drug; Emergency Medical Services; | 2013 |
[Uncertain if drugs do any good after cardiac arrest].
Topics: Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Epinephrine; Heart Arrest; Humans | 2015 |
Amiodarone and cardiac arrest: Systematic review and meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Observational Studies as Topic; Patient Ad | 2016 |
Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Combined Modality Therapy; Electric Countershock; Heart A | 2017 |
Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benchmarking; Cardiac Surgical Procedures; Cardiopulmonary | 2008 |
The "Code Drugs in Cardiac Arrest"--the use of cardioactive medications in cardiac arrest resuscitation.
Topics: Advanced Cardiac Life Support; Amiodarone; Atropine; Cardiotonic Agents; Epinephrine; Heart Arrest; | 2012 |
Amiodarone supplants lidocaine in ACLS and CPR protocols.
Topics: Action Potentials; Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Bretylium Comp | 2011 |
Strategies for reversing shock-resistant ventricular fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonar | 2003 |
Cardiopulmonary Resuscitation Guidelines 2000 update: what's happened since?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; Emergency | 2003 |
Update on advanced life support and resuscitation techniques.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Electri | 2005 |
[Resuscitation after prehospital cardiovascular arrest].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Defibrillators; Emergency Medical | 2005 |
Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Clinical Trials as Topic; Disease Models, Animal; Drug | 2007 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
Sudden death prevention in patients with advanced ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Su | 1993 |
Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Heart Arrest; Humans; Randomized Co | 1997 |
Innovative pharmacologic approaches to cardiopulmonary resuscitation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiopulmonary Resuscitation; | 1998 |
Prevention of sudden cardiac death: a current perspective.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 1998 |
Management of malignant ventricular arrhythmias and cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Defibrillators | 2000 |
Advanced cardiac life support antiarrhythmic drugs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Cli | 2002 |
Antiarrhythmic drug therapy in the management of cardiac arrest survivors.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrophysiology; Heart Arrest; Humans; Recurrence | 1992 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
Pharmacologic therapy for survivors of sudden death based on programmed stimulation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Death, Sudden; Heart; Heart Arrest; | 1985 |
14 trials available for amiodarone and Heart Arrest
| Article | Year |
|---|---|
Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Emergenc | 2010 |
Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Cardiac | 2003 |
Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Techniques, Card | 2004 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprol | 2006 |
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Hea | 1994 |
Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Electrocardiography, Ambulatory; | 1993 |
Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Electrocardiography, Ambulatory; | 1993 |
Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Double-Blind Method; Electr | 1999 |
In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Defibrillators, Implantable | 1999 |
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Heart Arrest; Humans; | 2000 |
Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Double-Blind Method; Electric C | 2002 |
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Female; Heart Arrest; Humans; L | 1991 |
122 other studies available for amiodarone and Heart Arrest
| Article | Year |
|---|---|
Regarding the Comparative Effectiveness of Lidocaine and Amiodarone for Treatment of In-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Heart Arrest; Hospitals; Humans; | 2023 |
Frequency of Advanced Cardiac Life Support Medication Use and Association With Survival During In-hospital Cardiac Arrest.
Topics: Advanced Cardiac Life Support; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Uti | 2020 |
Retrospective evaluation of resuscitation medication utilization in hospitalized adult patients with cardiac arrest.
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiopulmonary Resuscitation; Coronary Circulation; Epinephrin | 2020 |
Successful management of ventricular fibrillation and ventricular tachycardia using defibrillation and intravenous amiodarone therapy in a cat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cardiopulmonary Resuscita | 2020 |
Decreasing the Stress of Medication Management During Cardiac Arrest.
Topics: Amiodarone; Cardiopulmonary Resuscitation; Epinephrine; Heart Arrest; Humans; Medication Therapy Man | 2020 |
Assessing the confidence in network meta-analysis results.
Topics: Amiodarone; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2021 |
The authors respond: Assessing the confidence in network meta-analysis results.
Topics: Amiodarone; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2021 |
Outcomes associated with lidocaine and amiodarone administration in pediatric in-hospital cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Heart Arrest; Hospitals; Humans; Lidocaine; Ventricular F | 2021 |
Earlobe Crease in Patient With Chest Pain.
Topics: Aged; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Bundle-Branch Block; Coronary Occlusion; | 2017 |
Cardiac Arrest in 2 Neonates Receiving Amiodarone and Dexmedetomidine.
Topics: Amiodarone; Analgesics, Non-Narcotic; Anti-Arrhythmia Agents; Dexmedetomidine; Drug Therapy, Combina | 2017 |
Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Heart Arrest; Humans; Middle Aged; Tachycardia, Ventricu | 2018 |
[Accidental poisoning with aconite napel (monkshood) : Simultaneous treatment of two patients].
Topics: Aconitum; Adult; Amiodarone; Female; Heart Arrest; Humans; Poisoning; Potassium Channel Blockers; Re | 2018 |
[An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Heart Arrest; Humans | 2018 |
Bizarre and scary ECG in yew leaves poisoning: Report of successful treatment.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Ca | 2018 |
Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atropine; Bicarbonates; Calcium; Epinephrine; Female; Gluc | 2019 |
European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child; Electric Countersho | 2019 |
In reply to "Animal models for neurotoxicity assessment in cardiac arrest".
Topics: Amiodarone; Animals; Brain Injuries; Cardiopulmonary Resuscitation; Heart Arrest; Models, Animal; Pr | 2019 |
Animal models for neurotoxicity assessment in cardiac arrest.
Topics: Amiodarone; Animals; Brain Injuries; Cardiopulmonary Resuscitation; Heart Arrest; Models, Animal; Pr | 2019 |
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Em
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emerg | 2018 |
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Heart Ar | 2020 |
Safety of therapeutic hypothermia in post VF/VT cardiac arrest patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Arrest; Humans; Hypothermia, | 2013 |
Dronedarone and Captisol-enabled amiodarone in an experimental cardiac arrest.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiopulmonary Resuscitation; Disease | 2013 |
Case of sorafenib-induced thyroid storm.
Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Atrial Fib | 2013 |
Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Coronary Vessels; Diseas | 2013 |
Early coronary revascularization improves 24h survival and neurological function after ischemic cardiac arrest. A randomized animal study.
Topics: Amiodarone; Animals; Cardiac Catheterization; Cardiopulmonary Resuscitation; Disease Models, Animal; | 2014 |
Effects of early amiodarone administration during and immediately after cardiopulmonary resuscitation in a swine model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; E | 2014 |
Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Cohort Studies; Heart Arres | 2014 |
Adrenaline increases blood-brain-barrier permeability after haemorrhagic cardiac arrest in immature pigs.
Topics: Amiodarone; Animals; Blood-Brain Barrier; Capillary Permeability; Cardiopulmonary Resuscitation; Cer | 2014 |
Resuscitation with amiodarone increases survival after hemorrhage and ventricular fibrillation in pigs.
Topics: Amiodarone; Animals; Antidiuretic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; | 2014 |
Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clarithromycin; Drug Therapy, Combination; Electrocardiography; | 2014 |
Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation.
Topics: Amiodarone; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Disease Models, Animal; Electric | 2015 |
Cardiac arrest in Antarctica--a successful outcome.
Topics: Amiodarone; Antarctic Regions; Cardiopulmonary Resuscitation; Electric Countershock; Epinephrine; He | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart | 2016 |
Amiodarone administration for refractory ventricular fibrillation or pulseless ventricular tachycardia.
Topics: Administration, Intravenous; Adult; Amiodarone; Anti-Arrhythmia Agents; Emergency Nursing; Heart Arr | 2016 |
In Patients With Cardiac Arrest, Does Amiodarone or Lidocaine Increase Meaningful Survival?
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Lidocaine; Ventricular Fibrillation | 2017 |
Comparison of the effects of sternal and tibial intraosseous administered resuscitative drugs on return of spontaneous circulation in a swine model of cardiac arrest.
Topics: Administration, Intravenous; Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitat | 2016 |
The effects of tibial intraosseous versus intravenous amiodarone administration in a hypovolemic cardiac arrest procine model.
Topics: Amiodarone; Animals; Cardiopulmonary Resuscitation; Chromatography, High Pressure Liquid; Disease Mo | 2016 |
The effects of sternal intraosseous and intravenous administration of amiodarone in a hypovolemic swine cardiac arrest model.
Topics: Amiodarone; Animals; Cardiopulmonary Resuscitation; Chromatography, High Pressure Liquid; Disease Mo | 2016 |
Effects of humerus intraosseous versus intravenous amiodarone administration in a hypovolemic porcine model.
Topics: Amiodarone; Animals; Cardiopulmonary Resuscitation; Chromatography, High Pressure Liquid; Disease Mo | 2016 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Coca | 2008 |
Recurrence of cardiotoxicity after lipid rescue from bupivacaine-induced cardiac arrest.
Topics: Adult; Amiodarone; Anesthetics, Local; Anti-Arrhythmia Agents; Brachial Plexus; Bupivacaine; Cardiop | 2009 |
Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Atrial Fibrillation; Ciprofloxacin; | 2009 |
A case of fatal caffeine poisoning.
Topics: Amiodarone; Anti-Arrhythmia Agents; Caffeine; Cardiopulmonary Resuscitation; Central Nervous System | 2010 |
Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Disease Models, Animal; | 2010 |
PMS: premenstrual storm? An unusual cause of electrical storm in a young woman with vasospastic angina.
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Biomarkers; Defibrillators, Implantable; Diltiazem; Dru | 2011 |
Acute rhabdomyolysis and cardiac arrest following succinylcholine in a patient with Parry-Romberg syndrome.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Calcium Gluconate; Cardiopulmonary Re | 2011 |
[Update on current care guidelines: resuscitation].
Topics: Advance Directives; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Epinephrine; | 2011 |
Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Impl | 2011 |
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.
Topics: Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; D | 2012 |
Amiodarone versus lidocaine for shock-resistant ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Heart Arrest; Hospitalization; Humans; Li | 2002 |
Life after a ventricular arrhythmia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Follow-Up Studies; He | 2002 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Car | 2002 |
Incremental net benefit in randomized clinical trials with quality-adjusted survival.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Health Care Costs; Heart Arrest; Humans; | 2003 |
Clusters of ventricular fibrillation in a patient with an implantable cardioverter difibrillator treated with amiodarone.
Topics: Adult; Amiodarone; Angioplasty, Balloon, Coronary; Defibrillators, Implantable; Electrocardiography; | 2003 |
Successful resuscitation of a patient with electrical storm.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Electric Countershock; Female; | 2003 |
Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiologic Tec | 2003 |
The role of amiodarone in the management of patients with cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Heart Arrest; Humans; Practice Gu | 2000 |
Effect of amiodarone on haemodynamics during cardiopulmonary resuscitation in a canine model of resistant ventricular fibrillation.
Topics: Amiodarone; Animals; Cardiopulmonary Resuscitation; Dogs; Drug Therapy, Combination; Electric Counte | 2003 |
Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest.
Topics: Amiodarone; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Coronary Vessels; Disease Models | 2003 |
[Bradycardia-tachycardia syndrome during spinal anesthesia].
Topics: Aged; Amiodarone; Anesthesia, Spinal; Aneurysm; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; | 2003 |
Cardiovascular collapse after amiodarone administration in neonatal supraventicular tachycardia.
Topics: Adenosine; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Emergency Medicine; Extracorpor | 2003 |
Images in cardiovascular medicine. Fatal bidirectional and polymorphic ventricular tachycardia with terminal depolarization abnormality in a child.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Combined Modality Therap | 2004 |
The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest.
Topics: Aged; Amiodarone; Blood Pressure; Dose-Response Relationship, Drug; Emergency Medical Services; Fema | 2004 |
[Changes in the management of cardiac arrest].
Topics: Adult; Aftercare; Algorithms; Amiodarone; Cardiopulmonary Resuscitation; Cardiovascular Agents; Deci | 2004 |
Regression methods for cost-effectiveness analysis with censored data.
Topics: Amiodarone; Anti-Arrhythmia Agents; Canada; Cost-Benefit Analysis; Defibrillators, Implantable; Fema | 2005 |
Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Combined Modality Therapy; Dose-Response Relationship, Drug; El | 2006 |
The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres.
Topics: Amiodarone; Anti-Arrhythmia Agents; Canada; Emergency Medical Services; Heart Arrest; Hospitals; Hum | 2006 |
Amiodarone and apparently unimproved survival from in-hospital cardiac arrest: association, causation or a mix of both?
Topics: Amiodarone; Anti-Arrhythmia Agents; Canada; Emergency Medical Services; Heart Arrest; Hospitals; Hum | 2006 |
Application of normothermic cardiac arrest algorithms to hypothermic cardiac arrest in a canine model.
Topics: Adrenergic alpha-Agonists; Algorithms; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, | 2006 |
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hear | 2006 |
Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Bradyc | 2006 |
Colon ischaemia and necrosis as a complication of prolonged but successful CPR.
Topics: Adrenergic Agonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Colec | 2006 |
AVID revisited: quality of life is important too.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Heart Arrest; Humans; | 2008 |
Drug interactions with amiodarone.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Benzofurans; Blo | 1983 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; H | 1984 |
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography | 1984 |
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Anorexia; Ataxia; Benzofurans; Female; Heart Arrest; Humans; Lung Diseases; Male; | 1983 |
Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Death, Sudden; Dose-Response Relationshi | 1984 |
Sinus arrest during treatment with amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Heart Arrest; Humans; Male; Middle Aged; | 1982 |
Sinus arrest during treatment with amiodarone.
Topics: Amiodarone; Benzofurans; Digoxin; Drug Interactions; Heart Arrest; Humans | 1982 |
Sinoatrial arrest due to lidocaine injection in sick sinus syndrome during amiodarone administration.
Topics: Amiodarone; Anesthesia, Local; Benzofurans; Cardiac Pacing, Artificial; Drug Interactions; Heart Arr | 1982 |
Possible amiodarone-aprindine interaction.
Topics: Adult; Amiodarone; Aortic Valve Insufficiency; Aprindine; Benzofurans; Cardiomyopathy, Hypertrophic; | 1982 |
Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Electrophysiology; Heart Arrest | 1995 |
Optimal defibrillation strategy and follow-up of out-of-hospital cardiac arrest. The Belgian CPCR Study Group.
Topics: Amiodarone; Anti-Arrhythmia Agents; Belgium; Coronary Artery Bypass; Defibrillators, Implantable; El | 1996 |
Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Chagas Cardiomyopathy; | 1997 |
Assessment of the cardiac patient for fitness to drive: 1996 update.
Topics: Amiodarone; Arrhythmias, Cardiac; Automobile Driving; Defibrillators, Implantable; Electrocardiograp | 1996 |
[Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Heart Arrest; Humans; Middle | 1997 |
Implantable cardioverter defibrillators--for whom?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Output, Low; Cause of Death; Coronary Artery Bypass; Dec | 1998 |
Drug-induced torsade de pointes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Arrest; Humans; Male; Procainam | 1999 |
Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Follow-Up Stu | 1999 |
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Child; Death, S | 1999 |
Amiodarone in out-of-hospital cardiac arrest.
Topics: Amiodarone; Electric Countershock; Emergency Medical Services; Epinephrine; Heart Arrest; Humans; Su | 2000 |
Acute fatal vasoplegia and asystole induced by intravenous amiodarone after cardiopulmonary bypass in a patient with preoperative cardiogenic shock.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Fatal Outcome; Female; Heart Arrest; Hum | 1999 |
Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant?
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Circadian Rhythm; Defibrillators, Implantable; Electrocar | 2000 |
An old drug with new tricks. Amiodarone hits the streets.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Contraindications; Electrocardiography; Em | 2000 |
Intravenous amiodarone in cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Injections, Intravenous | 2001 |
Incremental net benefit in randomized clinical trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cost-Benefit Analysis; Defibrillators, Im | 2001 |
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Arrest; Hu | 2002 |
[Amiodarone and propanolol: a dangerous combination?].
Topics: Amiodarone; Benzofurans; Drug Therapy, Combination; Heart Arrest; Humans; Propranolol; Ventricular F | 1979 |
Catecholamine-sensitive right ventricular tachycardia in the absence of structural heart disease: a mechanism of exercise-induced cardiac arrest.
Topics: Adult; Amiodarone; Basketball; Bundle of His; Bundle-Branch Block; Cardiac Pacing, Artificial; Catec | 1991 |
Sudden cardiac death while taking amiodarone therapy: the role of abnormal repolarization.
Topics: Adult; Amiodarone; Electrocardiography; Electrophysiology; Heart Arrest; Humans; Long QT Syndrome; M | 1991 |
Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Child; Death, Sudden; Electric Cou | 1990 |
Designing clinical trials in the post CAST era--where do we go from here?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; F | 1991 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action | 1985 |
Intravenous amiodarone during prolonged resuscitation from cardiac arrest.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Heart Arrest; Humans; Infusions, Intravenous; In | 1989 |
Comparative evaluation of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardio | 1985 |
[Symposium: Sudden cardiac death. The importance of amiodarone in the treatment of life-threatening arrhythmia. Munich, 10-11 June 1988].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden; Heart Arrest; Humans | 1988 |
Long-term results of amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Follow-Up Studies; Heart Arrest; Humans; Middle Aged; | 1987 |
Ventricular fibrillation in a patient with 'silent' mitral valve prolapse.
Topics: Adult; Amiodarone; Death, Sudden; Drug Therapy, Combination; Electrophysiology; Follow-Up Studies; H | 1988 |
[Remote results of the pharmacological treatment of patients with a high risk of sudden heart arrest in ventricular disorders of cardiac rhythm].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Female; Heart Arrest; Humans; Male; Mexiletine; Middle Aged; | 1987 |
Asystole produced by the combination of amiodarone and digoxin.
Topics: Amiodarone; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Electrocardiography; Heart Arrest; Hum | 1987 |
Electrophysiologic testing and follow-up of patients with aborted sudden death.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheteri | 1987 |
Amiodarone-induced torsades de pointes.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Dru | 1986 |
Sinus arrest with intravenous amiodarone.
Topics: Amiodarone; Female; Heart Arrest; Humans; Injections, Intravenous; Middle Aged | 1986 |
Selection of antiarrhythmic drugs based on electrophysiologic studies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiolo | 1985 |
Asystole during treatment with amiodarone in a patient with persistent atrial tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Digoxin; Drug Therapy, | 1985 |
Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Di | 1986 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; H | 1986 |
Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
Topics: Aged; Amiodarone; Analysis of Variance; Benzofurans; Death, Sudden; Female; Heart Arrest; Humans; Ma | 1985 |
The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Heart Arres | 1985 |